MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NVCT has $31,709K in assets. $13,296K in debts. $31,634K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
238.49%
Quick Ratio
238.49%
Cash Ratio
237.92%
Debt to Asset Ratio
41.93%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other current assets
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Employee compensation and benefi...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
31,634
Other current assets
75
Total current assets
31,709
Total assets
31,709
Accounts payables
6,274
Accrued liabilities
115
Employee compensation and benefits
6,907
Total current liabilities
13,296
Total liabilities
13,296
Additional paid in capital
118,100
Accumulated deficit
-99,687
Total shareholders' equity
18,413
Total liabilities and shareholders' equity
31,709
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$31,634K Other current assets$75K Total current assets$31,709K Total assets$31,709K Total liabilities andshareholders' equity$31,709K Total shareholders'equity$18,413K Total liabilities$13,296K Accumulated deficit-$99,687K Additional paid in capital$118,100K Total currentliabilities$13,296K Employee compensationand benefits$6,907K Accounts payables$6,274K Accrued liabilities$115K

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma, Inc. (NVCT)